SCHEMBL9975306

SCHEMBL9975306

CCC[C@@H](C)NC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1100278 1.00
Hydrochloric Acid SCHEMBL1821666 0.97
Formic Acid SCHEMBL31326327 0.84 ADH1B (0.38)
SCHEMBL22699876 0.83 TSHR (0.42)
SCHEMBL27254821 0.83 METAP1 (0.32)
SCHEMBL12734622 0.81
SCHEMBL12227632 0.81
SCHEMBL1687784 0.81
SCHEMBL14444137 0.79
SCHEMBL7049293 0.79

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2658870-B1 CONJUGATED ANTI-CD38 ANTIBODIES TAKEDA PHARMACEUTICALS CO (JP) 2018-04-25 EP disclosed
WO-2017047992-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME 주식회사 엘지화학 2017-03-23 WO disclosed
WO-2017047993-A1 COMPOUND AND ORGANIC LIGHT EMITTING DEVICE CONTAINING SAME 주식회사 엘지화학 2017-03-23 WO disclosed
WO-2016105448-A1 IMIDAZOLINE RECEPTOR TYPE 1 LIGANDS FOR USE AS THERAPEUTICS RIDEOUT DARRYL (US) 2016-06-30 WO disclosed
US-20140135270-A1 MACROCYCLIC COMPOUNDS FOR INHIBITION OF INHIBITORS OF APOPTOSIS BRISTOL-MYERS SQUIBB COMPANY 2014-05-15 US disclosed
US-8202879-B2 Quinazoline derivatives having tyrosine kinase inhibitory activity SHIONOGI & CO., LTD. (JP) 2012-06-19 US disclosed
US-20090143414-A1 Quinazoline Derivatives Having Tyrosine Kinase Inhibitory Activity SHIONOGI & CO., LTD. (JP) 2009-06-04 US disclosed